Raia Drogasil S.A.
B3:RADL3.SA
25.34 (BRL) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) BRL.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 33,973.79 | 29,067.38 | 24,127.002 | 20,066.84 | 17,565.6 | 14,801.445 | 13,212.505 | 11,256.565 | 8,897.849 | 7,391.569 | 6,232.919 | 5,380.728 | 2,729.392 | 2,005.216 | 1,720.548 | 1,260.147 | 833.069 | 674.425 | 539.166 | 426.918 | 344.673 |
Cost of Revenue
| 25,427.772 | 20,257.912 | 16,920.834 | 14,175.708 | 12,367.239 | 10,355.923 | 9,224.505 | 7,752.422 | 6,183.289 | 5,281.377 | 4,512.743 | 3,888.079 | 2,011.471 | 1,526.818 | 1,321.698 | 965.989 | 606.235 | 489.909 | 390 | 305.943 | 237.064 |
Gross Profit
| 8,546.018 | 8,809.468 | 7,206.168 | 5,891.132 | 5,198.361 | 4,445.522 | 3,988 | 3,504.143 | 2,714.56 | 2,110.192 | 1,720.176 | 1,492.649 | 717.921 | 478.398 | 398.85 | 294.158 | 226.834 | 184.516 | 149.166 | 120.975 | 107.609 |
Gross Profit Ratio
| 0.252 | 0.303 | 0.299 | 0.294 | 0.296 | 0.3 | 0.302 | 0.311 | 0.305 | 0.285 | 0.276 | 0.277 | 0.263 | 0.239 | 0.232 | 0.233 | 0.272 | 0.274 | 0.277 | 0.283 | 0.312 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1,503.526 | 1,249.847 | 912.334 | 699.757 | 548.713 | 416.481 | 328.664 | 297.729 | 235.088 | 194.958 | 176.463 | 171.45 | 0 | 51.694 | 56.234 | 40.372 | 26.965 | 3.218 | 22.188 | 17.638 | 16.693 |
Selling & Marketing Expenses
| 6,689.275 | 5,805.992 | 4,966.819 | 4,256.422 | 3,754.77 | 3,261.896 | 2,529.05 | 2,218.765 | 1,742.093 | 1,409.067 | 1,188.077 | 1,002.33 | 464.112 | 317.663 | 0 | 194.11 | 148.043 | 120.938 | 106.849 | 83.366 | 71.144 |
SG&A
| 6,531.455 | 7,055.839 | 5,879.153 | 4,956.179 | 4,303.483 | 3,678.377 | 2,857.714 | 2,516.494 | 1,977.181 | 1,604.025 | 1,364.54 | 1,173.78 | 464.112 | 369.357 | 56.234 | 234.482 | 175.008 | 124.156 | 129.037 | 101.004 | 87.837 |
Other Expenses
| 102.793 | -80.536 | -47.483 | 7.359 | -0.798 | -0.716 | 337.702 | 282.111 | 236.516 | 197.041 | 205.802 | 158.245 | 174.252 | -3.188 | 245.811 | -0.174 | -0.163 | 52.651 | 0.667 | 2.047 | 0.485 |
Operating Expenses
| 6,428.662 | 6,975.303 | 5,831.67 | 4,963.538 | 4,303.483 | 3,678.377 | 3,195.416 | 2,798.605 | 2,213.697 | 1,801.066 | 1,570.342 | 1,332.025 | 638.364 | 366.169 | 302.045 | 263.081 | 203.489 | 211.391 | 136.529 | 112.402 | 98.513 |
Operating Income
| 2,117.356 | 1,479.919 | 1,222.391 | 854.196 | 785.075 | 721.51 | 792.584 | 705.538 | 88.786 | 309.126 | 149.834 | 160.624 | 79.557 | 112.229 | 96.805 | 47.877 | 23.345 | -26.875 | 12.637 | 8.573 | 9.096 |
Operating Income Ratio
| 0.062 | 0.051 | 0.051 | 0.043 | 0.045 | 0.049 | 0.06 | 0.063 | 0.01 | 0.042 | 0.024 | 0.03 | 0.029 | 0.056 | 0.056 | 0.038 | 0.028 | -0.04 | 0.023 | 0.02 | 0.026 |
Total Other Income Expenses Net
| -888.154 | -286.71 | -235.129 | -237.828 | -0.907 | -82.654 | -106.04 | -110.322 | 347.116 | -6.902 | -10.447 | -2.55 | 11.648 | 8.6 | 8.415 | 21.893 | 7.657 | 54.922 | 0.667 | 2.047 | 0.485 |
Income Before Tax
| 1,229.202 | 1,193.209 | 987.262 | 616.368 | 784.168 | 638.856 | 686.544 | 595.216 | 435.902 | 302.224 | 139.387 | 158.074 | 91.205 | 120.829 | 105.22 | 69.77 | 31.002 | 28.047 | 13.304 | 10.62 | 9.581 |
Income Before Tax Ratio
| 0.036 | 0.041 | 0.041 | 0.031 | 0.045 | 0.043 | 0.052 | 0.053 | 0.049 | 0.041 | 0.022 | 0.029 | 0.033 | 0.06 | 0.061 | 0.055 | 0.037 | 0.042 | 0.025 | 0.025 | 0.028 |
Income Tax Expense
| 129.55 | 178.241 | 223.129 | 120.835 | -4.567 | 129.543 | 173.891 | 143.964 | 96.117 | 80.838 | 38.402 | 53.219 | 22.509 | 31.814 | 30.63 | 18.597 | 9.376 | 82.849 | 3.44 | 2.71 | 2.467 |
Net Income
| 1,054.973 | 996.112 | 751.934 | 484.444 | 772.24 | 502.447 | 511.163 | 447.685 | 340.206 | 221.386 | 100.985 | 104.855 | 68.696 | 89.015 | 74.59 | 51.173 | 21.626 | 20.795 | 9.725 | 7.951 | 6.959 |
Net Income Ratio
| 0.031 | 0.034 | 0.031 | 0.024 | 0.044 | 0.034 | 0.039 | 0.04 | 0.038 | 0.03 | 0.016 | 0.019 | 0.025 | 0.044 | 0.043 | 0.041 | 0.026 | 0.031 | 0.018 | 0.019 | 0.02 |
EPS
| 0.62 | 0.58 | 0.44 | 0.28 | 0.45 | 0.29 | 0.3 | 0.26 | 0.2 | 0.13 | 0.059 | 0.061 | 0.042 | 0.095 | 0.081 | 0.056 | 0.022 | 0.028 | 0.013 | 0.011 | 0.01 |
EPS Diluted
| 0.62 | 0.58 | 0.44 | 0.28 | 0.45 | 0.29 | 0.3 | 0.26 | 0.2 | 0.13 | 0.059 | 0.061 | 0.042 | 0.095 | 0.08 | 0.056 | 0.022 | 0.028 | 0.013 | 0.011 | 0.01 |
EBITDA
| 3,778.702 | 2,995.457 | 2,549.501 | 2,031.478 | 1,826.108 | 1,099.871 | 1,027.929 | 885.044 | 666.323 | 490.727 | 300.305 | 284.212 | 157.676 | 157.636 | 131.849 | 49.453 | 50.361 | 57.827 | 23.405 | 23.592 | 22.89 |
EBITDA Ratio
| 0.111 | 0.103 | 0.106 | 0.101 | 0.104 | 0.074 | 0.078 | 0.079 | 0.075 | 0.066 | 0.048 | 0.053 | 0.058 | 0.079 | 0.077 | 0.039 | 0.06 | 0.086 | 0.043 | 0.055 | 0.066 |